Colorectal Cancer

  • Eugene OrientaleJr.
  • Gregory Dabov
  • William Macmillan Rodney


Colorectal cancer, one of the most prevalent cancers in the Western world, is a leading cause of death from cancer in the United States. Some 150,000 new cases and 60,900 deaths were reported in 1990 alone. Although risks for colon cancer in men and women are similar, men have a higher incidence of rectal cancer. There is no difference of risk in Blacks versus Whites. Despite advances in early detection, screening, and treatment, the age-adjusted death rates have remained relatively unchanged since the recording of such data began during the 1930s. The “graying” of the population makes it imperative that family physicians remain on the vanguard of implementing colorectal cancer screening as we enter the twenty-first century.


Colorectal Cancer Colon Cancer Positive Predictive Value Family Physician Fecal Occult Blood Test 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Chait M, Herbert E, Guthrie M, et al. The Memorial Sloan-Kettering Cancer Center-Strang Clinic program: a progress report. Gastrointest Res 1986;10:102–11.Google Scholar
  2. 2.
    Rodney WM, Chun JD, Johnson RA. Colorectal cancer: screening, treatment and postsurgical follow-up. Semin Fam Med 1981; 2:267–78.Google Scholar
  3. 3.
    Ross CC. Screening for colorectal cancer. Am Fam Physician 1988;38(16):105–114.PubMedGoogle Scholar
  4. 4.
    Eddy DM. Screening for colorectal cancer. Ann Intern Med 1990;113:373–84.PubMedCrossRefGoogle Scholar
  5. 5.
    Ransahoff DF, Lang CA. Screening for colorectal cancer. N Engl J Med 1991;325:37–41.CrossRefGoogle Scholar
  6. 6.
    Mayer AJ. Dose adjuvant therapy work in colon cancer? N Engl J Med 1990;322:352–8.CrossRefGoogle Scholar
  7. 7.
    Thun MJ, Mohan MN, Heath CW. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991;325:1593–6.PubMedCrossRefGoogle Scholar
  8. 8.
    Cohen AM. Management of colorectal cancer. Compr Ther 1990;16(11):43–50.PubMedGoogle Scholar
  9. 9.
    Peyster FA. Pathogenesis and manifestations. JAMA 1975;231: 643–5.CrossRefGoogle Scholar
  10. 10.
    Botsford TW, Wilson RE. The acute abdomen. 2nd ed. Philadelphia: Saunders, 1977:265–7.Google Scholar
  11. 11.
    Rodney WM. Screening for colorectal cancer: the rectal examination is not a screening test for fecal occult blood. Postgrad Med 1990;87(2):29–30.PubMedGoogle Scholar
  12. 12.
    Pye G, Ballantyne KC, Armitage NC, Hardcastle JD. Influence of non-steroidal antiinflammatory drugs on the outcome of fecal occult blood tests in screening for colorectal cancer. BMJ 1987;294:1510–11.PubMedCrossRefGoogle Scholar
  13. 13.
    Broderick FT, Harris SM, Meyer GW. False-positive hemoccult test not caused by turnips. N Engl J Med 1982;307:191.PubMedGoogle Scholar
  14. 14.
    Bahrt KM, Korman LY, Nashel DJ. Significance of a positive test for occult blood in stools of patients taking anti-inflammatory drugs. Arch Intern Med 1984;144:2165.Google Scholar
  15. 15.
    Hardcastle JD, Thomas WM, Chamberlin J, et al. Randomized controlled trial of fecal occult blood screening for colorectal cancer: results for first 107,349 subjects. Lancet 1989;1:1160–4.PubMedCrossRefGoogle Scholar
  16. 16.
    Dutton JJ. Sigmoidoscopy as a periodic screening test. J Fam Pract 1978;7:1041–6.PubMedGoogle Scholar
  17. 17.
    Selby JV, Friedman GD, Quesenberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:654–7.CrossRefGoogle Scholar
  18. 18.
    Rodney WM, Albers G. Flexible sigmoidoscopy: primary care outcomes after two types of continuing medical education. Am J Gastroenterol 1986;81:133–7.PubMedGoogle Scholar
  19. 19.
    Aldridge MC, Sim AJW. Colonoscopy findings in symptomatic patients without x-ray evidence of colonic neoplasms. Lancet 1986;2:833–4.PubMedCrossRefGoogle Scholar
  20. 20.
    Lieberman DA, Smith FW. Screening for colon malignancy with colonoscopy. Am J Gastroenterol 1991;86:946–51.PubMedGoogle Scholar
  21. 21.
    Rex DK, Lehman GA, Hawes RH, Ulbright TM, Smith J. Screening colonoscopy in asymptomatic average risk persons with negative fecal occult blood tests. Gastroenterology 1991;100:64–67.PubMedGoogle Scholar
  22. 22.
    Health & Public Policy Committee, American College of Physicians. Clinical competence in colonoscopy. Ann Intern Med 1987; 170:772–4.Google Scholar
  23. 23.
    Perry MB, Christensen JB, Christenson MA, Thorson AG. Office colonoscopy—a safe procedure in selected patients. Dis Colon Rectum 1989;32:1031–3.PubMedCrossRefGoogle Scholar
  24. 24.
    Rodney WM, Dabov G, Cronic C. Evolving colonoscopy skills in a rural family practice: the first 293 cases. Fam Pract Res J 1993; 13(1):43–52.PubMedGoogle Scholar
  25. 25.
    Rodney WM, Dabov G, Orientale E, Reeves WP. Colonoscopy in family practice: sedation is a more complete exam. J Am Fam Physician (in press).Google Scholar
  26. 26.
    Neugnt AI, Forde KA. Screening colonoscopy: has the time come? Am J Gastroenterol 1988;83:295–6.Google Scholar
  27. 27.
    Lindsay DC, Freeman JG, Cobden I, Record CO. Should colonoscopy be the first investigation for colonic disease? BMJ 1988; 296:167–169.PubMedCrossRefGoogle Scholar
  28. 28.
    American Cancer Society. 1989 Survey of physician’s attitudes and practices in early cancer detection. CA Cancer Clin J 1990;40: 77–99.Google Scholar
  29. 29.
    Stryker SJ, Wolff BG, Culp CE, et al. Natural history of untreated colonic polyps. Gastroenterology 1987;93:1009–13.PubMedGoogle Scholar
  30. 30.
    Provenzale D, Garrett JW, Condon SE, Sandler RS. Risk for colon adenomas in patients with rectosigmoid hyperplastic polyps. Ann Intern Med 1990;113:760–3.PubMedCrossRefGoogle Scholar
  31. 31.
    Rosato FE, Marks G. Changing site distribution patterns of colorectal cancer at Thomas Jefferson Hospital. Dis Colon Rectum 1981;25:93–95.CrossRefGoogle Scholar
  32. 32.
    Axtell LM, Chiazze L. Changing relative frequency of cancers of the colon and rectum in the United States. Cancer 1966;19:50–54.CrossRefGoogle Scholar
  33. 33.
    Tedesco FJ, et al. Diagnostic implications of the spatial distribution of colonic mass lesions (polyps and cancer). Gastrointest Endosoc 1987;26(3):95–97.CrossRefGoogle Scholar
  34. 34.
    Fry R, Fleshman J, Kodner I. Cancer of the colon and rectum. Clin Symp 1989;41(5):2–32.PubMedGoogle Scholar
  35. 35.
    Adjuvant therapy for patients with colon and rectal cancer-NIH Consensus Conference. JAMA 1990;265:1444–50.Google Scholar
  36. 36.
    Eddy DM. Designing a practice policy: standards, guidelines, and options. JAMA 1990;263:3077–84.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1994

Authors and Affiliations

  • Eugene OrientaleJr.
  • Gregory Dabov
  • William Macmillan Rodney

There are no affiliations available

Personalised recommendations